Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 956 publications

Combination treatment of mirabegron and solifenacin versus solifenacin monotherapy in female patients with overactive bladder - A comparative study on effectiveness, safety, symptoms and quality of life and treatment adherence.

Combination treatment of mirabegron and solifenacin versus solifenacin monotherapy in female patients with overactive bladder - A comparative study on effectiveness, safety, symptoms and quality of life and treatment adherence.

Journal: Urologia
Published: September 20, 2025

Long-term clinical efficacy and cognitive impact of medications for overactive bladder related to the central nervous system.

Long-term clinical efficacy and cognitive impact of medications for overactive bladder related to the central nervous system.

Journal: International urology and nephrology
Published: August 31, 2025

Behavioral Compared With Drug Therapy for Overactive Bladder Symptoms in Parkinson Disease: A Randomized Noninferiority Trial.

Behavioral Compared With Drug Therapy for Overactive Bladder Symptoms in Parkinson Disease: A Randomized Noninferiority Trial.

Journal: JAMA neurology
Published: July 14, 2025

Investigating the influence of mucus layer, bile acids, and pharmaceutical excipients on the intestinal permeability of solifenacin using PermeaPad™ plate.

Investigating the influence of mucus layer, bile acids, and pharmaceutical excipients on the intestinal permeability of solifenacin using PermeaPad™ plate.

Journal: Journal of pharmaceutical sciences
Published: July 03, 2025

Central Composite Design Assisted Spectrofluorimetric Determination of Solifenacin via Quenching of Acid Red 51: Application in Pharmaceutical Formulations and Plasma.

Central Composite Design Assisted Spectrofluorimetric Determination of Solifenacin via Quenching of Acid Red 51: Application in Pharmaceutical Formulations and Plasma.

Journal: Luminescence : the journal of biological and chemical luminescence
Published: July 02, 2025

The Efficacy and Safety Between Intradetrusor OnabotulinumtoxinA Injection and Combined Pharmacotherapy in Patients With Refractory Overactive Bladder: A Randomized Controlled Trial.

The Efficacy and Safety Between Intradetrusor OnabotulinumtoxinA Injection and Combined Pharmacotherapy in Patients With Refractory Overactive Bladder: A Randomized Controlled Trial.

Journal: The Journal of urology
Published: July 01, 2025

Combined use of mirabegron and solifenacin: new standards for successful treatment of overactive bladder

Combined use of mirabegron and solifenacin: new standards for successful treatment of overactive bladder

Journal: Urologiia (Moscow, Russia : 1999)
Published: May 16, 2025

Drug and behavioral therapy in the treatment of lower urinary tract symptoms that persist after surgical treatment of benign prostatic hyperplasia

Drug and behavioral therapy in the treatment of lower urinary tract symptoms that persist after surgical treatment of benign prostatic hyperplasia

Journal: Urologiia (Moscow, Russia : 1999)
Published: May 16, 2025

Escitalopram can reverse co-occurring depression and overactive bladder induced by corticosterone in rats.

Escitalopram can reverse co-occurring depression and overactive bladder induced by corticosterone in rats.

Journal: European journal of pharmacology
Published: April 30, 2025

Assessment of efficacy of mirabegron, solifenacin, tadalafil 5 mg and combination therapy in female patients with overactive bladder: a double blinded multicenter prospective placebo-controlled trial.

Assessment of efficacy of mirabegron, solifenacin, tadalafil 5 mg and combination therapy in female patients with overactive bladder: a double blinded multicenter prospective placebo-controlled trial.

Journal: Minerva urology and nephrology
Published: April 23, 2025

Novel spectrophotometric approaches for analysis of solifenacin and silodosin in pharmaceutical preparations, human plasma, and environmental water samples: assessment of the methods' greenness and practicality.

Novel spectrophotometric approaches for analysis of solifenacin and silodosin in pharmaceutical preparations, human plasma, and environmental water samples: assessment of the methods' greenness and practicality.

Journal: Analytical and bioanalytical chemistry
Published: April 22, 2025

Additive effects of mirabegron on muscarinic receptor binding and on relaxation of cholinergic detrusor muscle contraction by antimuscarinics.

Additive effects of mirabegron on muscarinic receptor binding and on relaxation of cholinergic detrusor muscle contraction by antimuscarinics.

Journal: Journal of pharmacological sciences
Published: April 21, 2025
Showing 1-12 of 956

Last Updated: 10/31/2025